Sikandar Kher who is essaying the role of a police officer in his upcoming web series 'Tooth Pari: When Love Bites' revealed how he transformed to justify his role.
According to the internal memo that a US-based newspaper read, Meta's head of human resources, Lori Goler, wrote Tuesday evening that the company will begin notifying employees regarding the downsizing of technical teams.
With the start of the qualifying competition for the Parisian Grand Slam just five weeks away, the entry lists for the main draws of the women's and men's singles have now been revealed.
Researchers are increasingly using the blood-brain barrier, which allows only certain molecules to pass from the blood into the brain, to get therapies into the brain after a stroke.
The Special Investigation Team (SIT) formed to probe the murder of Atiq Ahmad and his brother Ashraf will soon recreate the crime scene as part of its ongoing investigation, revealed sources.
The wealth of Congress's Karnataka chief DK Shivakumar has increased by 68 per cent as compared to 2018, the affidavit filed by him while submitting his nomination papers filed for the May 10 Assembly polls have revealed.
Actor Sara Ali Khan who is gearing up for Homi Adajania's 'Murder Mubarak' on Tuesday revealed the best parts of her day by sharing a couple of videos on social media.
Salmonella infections kill about a million people worldwide each year, and better vaccines for both typhoid fever and non-typhoidal Salmonella disease are needed badly. Memory T cells, which are critical for a vaccine that induces a powerful immune response, can be recruited into the liver o
At least 17 people, including mastermind Pavittar Preet Singh, have been arrested in Northern California for a series of shootings within the Sikh community, local authorities revealed.
Elon Musk on Monday revealed he is going to develop his own version of an artificial intelligence chatbot, 'TruthGPT' during an interview with Tucker Carlson on Fox News.
A startling 89 per cent of desmoplastic melanoma patients in a nationwide clinical study responded to immunotherapy (pembrolizumab) alone, indicating that many patients could avoid the potential side effects of combination therapies and achieve disease control with this course of treatment.